Inventor · disambiguated record
Hui-Yuan Yu
Also filed as: YU HUI · YU HUI-YUAN
11 granted patents·5 pending applications·16 citations·filing 2004–2022
82Inventor score
Files withCRISPR THERAPEUTICS AG4UNIV NAT TSING HUA4CHENG JYA-WEI3RISE BIOPHARMACEUTICALS INC3CHENG TAO1
Top patents by PatentIndex Score
16 records- 0184US9073967B2High salt-resistance antibacterial peptide and method for producing the sameCHENG JYA-WEI·Filed 2012·Granted Jul 7, 2015·8 cites·5 claims
- 0280US9090655B2Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereofCHENG JYA-WEI·Filed 2011·Granted Jul 28, 2015·6 cites·11 claims
- 0368US10611799B2Anti-endotoxin polypeptideUNIV NAT TSING HUA·Filed 2017·Granted Apr 7, 2020·2 cites·3 claims
- 0458US2022193134A1Co-use of lenalidomide with car-t cellsCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 0558US2023046228A1Methods for manufacturing genetically engineered car-t cellsCRISPR THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0654US12472227B2Pharmaceutical compositions and use thereof for relieving resistance due to cancer chemotherapy and enhancing effect of cancer chemotherapyRISE BIOPHARMACEUTICALS INC·Filed 2021·Granted Nov 18, 2025·0 cites·3 claims
- 0754US9873719B2Salt and protease-resistance of antimicrobial peptide and the manufacture thereofUNIV NAT TSING HUA·Filed 2014·Granted Jan 23, 2018·0 cites·4 claims
- 0853US7863044B2p18 in stem cell manipulationsCHENG TAO·Filed 2004·Granted Jan 4, 2011·0 cites·15 claims
- 0953US2021139850A1Manufacturing process for making t cells expressing chimeric antigen receptorsCRISPR THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 1052US12329804B2Modified chemokine peptide and use thereofRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Jun 17, 2025·0 cites·4 claims
- 1150US2021139935A1Methods of manufacturing car-t cellsCRISPR THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 1245US12226454B2Pharmaceutical compositions and use thereof for relieving anticancer drug resistance and enhancing sensitivity of anticancer drugRISE BIOPHARMACEUTICALS INC·Filed 2020·Granted Feb 18, 2025·0 cites·3 claims
- 1339US8536116B2Antagonists for diseases induced by cells with high-affinity ELR-CXC chemokine receptor proteinsCHENG JYA-WEI·Filed 2012·Granted Sep 17, 2013·0 cites·11 claims
- 1438US10810329B2In silico design of peptides equilibrated in a lipid bilayer with partition free energies indicating probability of antimicrobial activityUNIV NAT TSING HUA·Filed 2016·Granted Oct 20, 2020·0 cites·7 claims
- 1534US10093699B2Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activitiesUNIV NAT TSING HUA·Filed 2016·Granted Oct 9, 2018·0 cites·31 claims
- 1634US2018125938A1Modified chemokine peptideRISE TECH CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hui-Yuan Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →